glp 1 agonists drugs GLP-1 Receptor and Research to Treat Overeating and Substance Use Disorders GLP-1 Agonists Weight Loss Drugs

People rush to the gym as soon as the new year starts to start prepping for the perfect body for summer

Trail registration Study registered in clinicaltrials.org with the identifier NCT05535322.

Metabolic Benefits: Along with weight loss, it has shown promising results in treating Type 2 diabetes, with some studies showing hemoglobin A1c reductions

Important Program Disclaimer

In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need

It should be noted that while GLP-1 agonists positively impact metabolism upstream of the liver, this may not subsequently improve the fibrotic liver injury within the tested treatment duration